christer fåhraeus

Insider profile

Performance

Overall performance
2.2

Performance over holding periods
2.2
30 days 90 days 120 days
Average return 7% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
2 0% Buy
34 71% Buy
47 69% Buy
christer fåhraeus's trades of EQL Pharma AB's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Sale
Price
340.93
Quantity 29,294
Value SEK3,109,212
Transaction date
Sale
Price
290.51
Quantity 79,435
Value SEK3,628,805
Transaction date
Sale
Price
240.79
Quantity 34,563
Value SEK3,182,262
Transaction date
Sale
Price
30.22
Quantity 90,000
Value SEK2,719,800
Transaction date
Purchase
Price
13.15
Quantity 4,495
Value SEK59,109
Transaction date
Purchase
Price
12.00
Quantity 230,000
Value SEK2,760,000
Transaction date
Purchase
Price
6.00
Quantity 26,543
Value SEK159,258
Transaction date
Purchase
Price
6.00
Quantity 1,698,922
Value SEK10,193,532
Transaction date
Purchase
Price
11.74
Quantity 10,300
Value SEK120,922
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2025-02-18 2025-02-17 S Sale
29,294
340.93
SEK3,109,212
29,294 340.93 SEK3,109,212
2024-03-15 2024-03-15 S Sale
79,435
290.51
SEK3,628,805
79,435 290.51 SEK3,628,805
2023-12-12 2023-12-12 S Sale
34,563
240.79
SEK3,182,262
34,563 240.79 SEK3,182,262
2023-11-24 2023-11-23 S Sale
90,000
30.22
SEK2,719,800
90,000 30.22 SEK2,719,800
2019-11-27 2019-11-25 B Purchase
4,495
13.15
SEK59,109
4,495 13.15 SEK59,109
2019-07-23 2019-07-19 B Purchase
230,000
12.00
SEK2,760,000
230,000 12.00 SEK2,760,000
2018-11-21 2018-11-21 B Purchase
26,543
6.00
SEK159,258
26,543 6.00 SEK159,258
2018-11-16 2018-11-13 B Purchase
1,698,922
6.00
SEK10,193,532
1,698,922 6.00 SEK10,193,532
2017-09-15 2017-09-15 B Purchase
10,300
11.74
SEK120,922
10,300 11.74 SEK120,922